A. van der Zee

First name
A.
Middle name
H. Maitland-
Last name
van der Zee
Mahmoudpour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., & van der Zee, A. H. M. -. (2016). Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13090
Oshagbemi, O. A., Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., Driessen, J. H. M., et al. (2017). Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.201701-0009LE
Ahmadizar, F., Souverein, P., de Boer, A., & van der Zee, A. H. M. -. (2018). Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13482
Mahmoudpour, S. H., Asselbergs, F. W., Souverein, P. C., de Boer, A., & van der Zee, A. H. M. -. (2018). Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13692
Oshagbemi, O. A., Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., van der Zee, A. H. M. -, et al. (2018). Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4655
Floyd, J. S., Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., et al. (2019). Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. PLoS One. http://doi.org/10.1371/journal.pone.0218115
Oshagbemi, O. A., Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. M. -, Driessen, J. H. M., de Boer, A., & de Vries, F. (2019). C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD. Pulm Pharmacol Ther. http://doi.org/10.1016/j.pupt.2019.101870
Oshagbemi, O. A., Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. M. -, et al. (2019). Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). Copd. http://doi.org/10.1080/15412555.2019.1608172
Zhang, Y., Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., van der Zee, A. H. M. -, & de Boer, A. (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14227